Read + Share
Amedeo Smart
Independent Medical Education
Veeraraghavan J, Gutierrez C, Sethunath V, Mehravaran S, et al. Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models. NPJ Breast Cancer 2021;7:63.PMID: 34045483
Email
LinkedIn
Facebook
Twitter
Privacy Policy